Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Insulin (API & Injection), Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Insulin (API & Injection) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Insulin (API & Injection) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Insulin (API & Injection) Market Size Growth Rate by Type
    • 1.4.2 Animal Insulin
    • 1.4.3 Human Insulin
    • 1.4.4 Insulin Analogue
  • 1.5 Market by Application
    • 1.5.1 Global Insulin (API & Injection) Market Size Growth Rate by Application
    • 1.5.2 Diabetes
    • 1.5.3 Coronary Heart Disease
    • 1.5.4 Perioperation Period
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Insulin (API & Injection) Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Insulin (API & Injection) Industry
      • 1.6.1.1 Insulin (API & Injection) Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Insulin (API & Injection) Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Insulin (API & Injection) Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Insulin (API & Injection) Market Size Estimates and Forecasts
    • 2.1.1 Global Insulin (API & Injection) Revenue 2015-2026
    • 2.1.2 Global Insulin (API & Injection) Sales 2015-2026
  • 2.2 Insulin (API & Injection) Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Insulin (API & Injection) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Insulin (API & Injection) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Insulin (API & Injection) Competitor Landscape by Players

  • 3.1 Insulin (API & Injection) Sales by Manufacturers
    • 3.1.1 Insulin (API & Injection) Sales by Manufacturers (2015-2020)
    • 3.1.2 Insulin (API & Injection) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Insulin (API & Injection) Revenue by Manufacturers
    • 3.2.1 Insulin (API & Injection) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Insulin (API & Injection) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Insulin (API & Injection) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Insulin (API & Injection) Revenue in 2019
    • 3.2.5 Global Insulin (API & Injection) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Insulin (API & Injection) Price by Manufacturers
  • 3.4 Insulin (API & Injection) Manufacturing Base Distribution, Product Types
    • 3.4.1 Insulin (API & Injection) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Insulin (API & Injection) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Insulin (API & Injection) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Insulin (API & Injection) Market Size by Type (2015-2020)
    • 4.1.1 Global Insulin (API & Injection) Sales by Type (2015-2020)
    • 4.1.2 Global Insulin (API & Injection) Revenue by Type (2015-2020)
    • 4.1.3 Insulin (API & Injection) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Insulin (API & Injection) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Insulin (API & Injection) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Insulin (API & Injection) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Insulin (API & Injection) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Insulin (API & Injection) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Insulin (API & Injection) Market Size by Application (2015-2020)
    • 5.1.1 Global Insulin (API & Injection) Sales by Application (2015-2020)
    • 5.1.2 Global Insulin (API & Injection) Revenue by Application (2015-2020)
    • 5.1.3 Insulin (API & Injection) Price by Application (2015-2020)
  • 5.2 Insulin (API & Injection) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Insulin (API & Injection) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Insulin (API & Injection) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Insulin (API & Injection) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Insulin (API & Injection) by Country
    • 6.1.1 North America Insulin (API & Injection) Sales by Country
    • 6.1.2 North America Insulin (API & Injection) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Insulin (API & Injection) Market Facts & Figures by Type
  • 6.3 North America Insulin (API & Injection) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Insulin (API & Injection) by Country
    • 7.1.1 Europe Insulin (API & Injection) Sales by Country
    • 7.1.2 Europe Insulin (API & Injection) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Insulin (API & Injection) Market Facts & Figures by Type
  • 7.3 Europe Insulin (API & Injection) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Insulin (API & Injection) by Region
    • 8.1.1 Asia Pacific Insulin (API & Injection) Sales by Region
    • 8.1.2 Asia Pacific Insulin (API & Injection) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Insulin (API & Injection) Market Facts & Figures by Type
  • 8.3 Asia Pacific Insulin (API & Injection) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Insulin (API & Injection) by Country
    • 9.1.1 Latin America Insulin (API & Injection) Sales by Country
    • 9.1.2 Latin America Insulin (API & Injection) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Insulin (API & Injection) Market Facts & Figures by Type
  • 9.3 Central & South America Insulin (API & Injection) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Insulin (API & Injection) by Country
    • 10.1.1 Middle East and Africa Insulin (API & Injection) Sales by Country
    • 10.1.2 Middle East and Africa Insulin (API & Injection) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Insulin (API & Injection) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Insulin (API & Injection) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Novo Nordisk
    • 11.1.1 Novo Nordisk Corporation Information
    • 11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
    • 11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novo Nordisk Insulin (API & Injection) Products Offered
    • 11.1.5 Novo Nordisk Recent Development
  • 11.2 Eli Lilly
    • 11.2.1 Eli Lilly Corporation Information
    • 11.2.2 Eli Lilly Description, Business Overview and Total Revenue
    • 11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Eli Lilly Insulin (API & Injection) Products Offered
    • 11.2.5 Eli Lilly Recent Development
  • 11.3 Sanofi-Aventis
    • 11.3.1 Sanofi-Aventis Corporation Information
    • 11.3.2 Sanofi-Aventis Description, Business Overview and Total Revenue
    • 11.3.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sanofi-Aventis Insulin (API & Injection) Products Offered
    • 11.3.5 Sanofi-Aventis Recent Development
  • 11.4 Dongbao
    • 11.4.1 Dongbao Corporation Information
    • 11.4.2 Dongbao Description, Business Overview and Total Revenue
    • 11.4.3 Dongbao Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Dongbao Insulin (API & Injection) Products Offered
    • 11.4.5 Dongbao Recent Development
  • 11.5 Bioton
    • 11.5.1 Bioton Corporation Information
    • 11.5.2 Bioton Description, Business Overview and Total Revenue
    • 11.5.3 Bioton Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bioton Insulin (API & Injection) Products Offered
    • 11.5.5 Bioton Recent Development
  • 11.6 United Laboratories
    • 11.6.1 United Laboratories Corporation Information
    • 11.6.2 United Laboratories Description, Business Overview and Total Revenue
    • 11.6.3 United Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 United Laboratories Insulin (API & Injection) Products Offered
    • 11.6.5 United Laboratories Recent Development
  • 11.7 Merck
    • 11.7.1 Merck Corporation Information
    • 11.7.2 Merck Description, Business Overview and Total Revenue
    • 11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Merck Insulin (API & Injection) Products Offered
    • 11.7.5 Merck Recent Development
  • 11.8 Ganlee
    • 11.8.1 Ganlee Corporation Information
    • 11.8.2 Ganlee Description, Business Overview and Total Revenue
    • 11.8.3 Ganlee Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Ganlee Insulin (API & Injection) Products Offered
    • 11.8.5 Ganlee Recent Development
  • 11.1 Novo Nordisk
    • 11.1.1 Novo Nordisk Corporation Information
    • 11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
    • 11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novo Nordisk Insulin (API & Injection) Products Offered
    • 11.1.5 Novo Nordisk Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Insulin (API & Injection) Market Estimates and Projections by Region
    • 12.1.1 Global Insulin (API & Injection) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Insulin (API & Injection) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Insulin (API & Injection) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Insulin (API & Injection) Sales Forecast (2021-2026)
    • 12.2.2 North America: Insulin (API & Injection) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Insulin (API & Injection) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Insulin (API & Injection) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Insulin (API & Injection) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Insulin (API & Injection) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Insulin (API & Injection) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Insulin (API & Injection) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Insulin (API & Injection) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Insulin (API & Injection) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Insulin (API & Injection) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Insulin (API & Injection) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Insulin (API & Injection) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Insulin (API & Injection) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Insulin (API & Injection) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Insulin (API & Injection) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Insulin (API & Injection) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Insulin (API & Injection) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Insulin (API & Injection) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Insulin (API & Injection) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Insulin (API & Injection) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Insulin (API & Injection) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insulin (API & Injection) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Insulin (API & Injection) market is segmented into
    Animal Insulin
    Human Insulin
    Insulin Analogue

    Segment by Application, the Insulin (API & Injection) market is segmented into
    Diabetes
    Coronary Heart Disease
    Perioperation Period
    Others

    Regional and Country-level Analysis
    The Insulin (API & Injection) market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Insulin (API & Injection) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Insulin (API & Injection) Market Share Analysis
    Insulin (API & Injection) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin (API & Injection) business, the date to enter into the Insulin (API & Injection) market, Insulin (API & Injection) product introduction, recent developments, etc.
    The major vendors covered:
    Novo Nordisk
    Eli Lilly
    Sanofi-Aventis
    Dongbao
    Bioton
    United Laboratories
    Merck
    Ganlee

    Buy now